Refine by
Eye Disease Suppliers & Manufacturers
40 companies found
based inNorwich, UNITED KINGDOM
Ikarovec was formed as a spin-out from the biotechnology company Quethera, which was acquired by Astellas Pharmaceuticals in 2018. Our technology allows for targeting multiple disease targets and pathways thereby improving efficacy and restoring ...
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 ...
based inHamburg, GERMANY
3B Scientific was founded in 1948 in Hamburg, Germany and has grown to be one of the world's leading manufacturers of Medical and Science Education solutions. The product portfolio covers a complete and comprehensive range of equipment for ...
This human eye model by 3B Scientific® shows an eye enlarged by a factor of 5. It is a perfect tool to assists the healthcare professional in educating patients in the anatomy and changes of the human ...
based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
based inTaipei City, TAIWAN
BRIM Biotechnology: bringing transformational treatments to patients sooner. BRIM Biotechnology applies integrated and efficient translational science to develop new treatments that help combat and cure disease. The company was founded in August ...
Our lead asset, BRM421, is on track to become a first-in-class treatment for Dry Eye Syndrome (DES) which treats and repairs corneal damage. BRIM Biotechnology is accelerating the cycle of innovation by leveraging its PDSP technology platform to ...
based inSouth San Francisco, CALIFORNIA (USA)
At UNITY we are developing therapeutics to slow, halt, or reverse diseases of aging. Working at the frontier of biotechnology and medicine, our mission is to develop therapeutics to extend the period of one’s life unburdened by disease. Our initial ...
UBX1325, a potent Bcl-xL inhibitor, is in clinical development for the treatment of age-related diseases of the eye, including diabetic macular edema (DME), age-related macular degeneration (AMD), and diabetic ...
based inTiburon, CALIFORNIA (USA)
OxyBand Technologies Inc. develops proprietary, patented, bio medical technologies that provide therapeutic gases such as oxygen and nitric oxide for traumatic & other acute wounds, diabetic & chronic skin ulcers, eye diseases, orthopedics, ...
OxyBand Technologies, Inc. is the first company to package pure oxygen into a discrete traditional wound dressing, using a directionally permeable gas emitting reservoir. OxyBand's patented technology delivers the therapeutic value of oxygen to ...
based inManchester, UNITED KINGDOM
For over 60 years, TAKAGI has been making ophthalmic instruments that assist doctors in preserving and restoring vision. A family-owned business to this day, every single one of TAKAGI’s slit lamps, operating microscopes and related devices is ...
SMTube is a new improved method (or dry eye testing in 5 seconds. The application method is simple, accurate and non-invasive. The tip of the SMTube strip is immersed into the tear meniscus of the lower eyelid for 5 seconds. During the application, ...
based inHerstal, BELGIUM
KiOmed Pharma, based in Belgium, is a biotech company that focuses on the development, manufacture and distribution of safe and effective medical devices based on KiOmedine CM-Chitosan, our innovative and exclusive animal-free bioresorbable ...
based inPARIS, FRANCE
FCI is a world leader in the development of a wide range of ophthalmic devices and is dedicated to providing physicians with innovative, high-performance and mostly exclusive products covering the fields of expertise of Oculoplasty, Dry Eye, Retina ...
based inManassas, VIRGINIA (USA)
Notal Vision is the first diagnostic services company to extend eye disease management from the clinic to the home and improve vision outcomes. By applying artificial intelligence (AI)-driven data interpretation to the unprecedented high volumes of ...
Notal Vision is developing a first-of-its-kind Artificial Intelligence-enabled digital diagnostic for patients with neovascular retina diseases using our patient-operated Home Optical Coherence Tomography device. The first disease in the Notal Home ...
based inPlanegg, GERMANY
We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound ...
This is a new type of drug for the treatment of thyroid diseases and the complications they cause in the heart and ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Pregnenolone monosulfate-d4 (sodium) is the deuterium labeled Pregnenolone monosulfate. Pregnenolone monosulfate sodium (3β-Hydroxy-5-pregnen-20-one monosulfate sodium) is a powerful neurosteroid, the main precursor of various steroid hormones ...
based inWaltham, MASSACHUSETTS (USA)
Kalaris was founded by experienced leaders in ophthalmology drug development and commercialization to address a major unmet need in the treatment of retinal diseases. Existing therapies for retinal neovascular / exudative diseases have made great ...
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative conditions. Their lead product, TH103, is a fully ...
based inDüsseldorf, GERMANY
The biotech research company was founded in 1993 and employs around 20 people with various scientific qualifications and experiences. Orthogen AG is a privately held Holdings Company located in Dusseldorf, Germany where its founder and CEO, Prof. ...
We co-pioneered the discovery and importance of biomolecular and biochemical as underlying key mechanisms. These processes are universal and generally apply to tissue aging as well as pathologies –independent of tissue and disease type– ...
based inAlpharetta, GEORGIA (US) (USA)
Clearside Biomedical is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). The platform provides an in-office, repeatable, non-surgical procedure, offering targeted ...
Clearside’s proprietary SCS injection treatment approach offers unprecedented access to the back of the eye where sight-threatening disease often occurs. The company’s unique platform is inherently ...
based inBangalore, INDIA
Strand Life Sciences is a genomics-based research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual’s genome. Strand Life Sciences partnership programs enable large-scale ...
based inKleinostheim, GERMANY
SCHWIND eye-tech-solutions is one of the technology leaders for eye lasers for refractive and therapeutic corneal surgery. We develop, produce and market a comprehensive product portfolio for the treatment of vision defects and corneal diseases. ...
Precise data on the corneal thickness and corneal wavefront in one step. SCHWIND SIRIUS+* offers detailed information regarding corneal thickness and comprehensive support for corneal diagnosis. The combination of a sophisticated 3D Scheimpflug ...
based inVadodara, INDIA
Care Group was founded in 1987 with an intent to manufacture and market Intraocular lenses and ophthalmic surgical products in Vadodara, India. Since then we have become a significant participant in the global ophthalmology industry. This is ...
based inArlington, MASSACHUSETTS (USA)
Kala is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus-penetrating particle (MPP) Drug Delivery ...
based inTucson, ARIZONA (USA)
Salutaris Medical Devices (SMD) is a clinical-stage medical device company specializing in the treatment of ophthalmic diseases with a precision beta radiotherapy delivery platform. Our globally-patented, 510k-cleared device has the potential to ...